Estimating transformations for repeated measures modeling of continuous bounded outcome data

Statistics in Medicine

Volumn 30, Issue 9, 2011, Pages 935-949

  Hutmacher, Matthew M ^a   French, Jonathan L ^b   Krishnaswami, Sriram ^b   Menon, Sujatha ^b  

^a ANN ARBOR PHARMACOMETRICS GROUP   (United States)

^b PFIZER INC   (United States)

Author keywords

Aranda Ordaz link function; Bounded outcome scores; Health assessment questionnaire; Left censoring, right censoring; Nonlinear mixed effects models

Indexed keywords

ARTICLE; CALCULATION; CONTINUOUS BOUNDED OUTCOME DATA; DATA ANALYSIS; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX; MATHEMATICAL MODEL; NONLINEAR SYSTEM; PROBABILITY; PROCESS DEVELOPMENT; RHEUMATOID ARTHRITIS; SIMULATION; STATISTICAL MODEL;

ARTHRITIS, RHEUMATOID; CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; HUMANS; JANUS KINASE 3; MODELS, STATISTICAL; PYRIMIDINES; PYRROLES; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 79953756267     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4155     Document Type: Article

References (43)

1. Box GEP, Cox DR. An analysis of transformation. Journal of the Royal Statistical Society, Series B 1964; 26:211-252.
2. Carroll RJ, Ruppert D. Transformation and Weighting in Regression. Chapman & Hall: London, 1988; 115-173.
3. Boik RJ, Todd C. Response transformations in repeated measures and growth curve models. Communications in Statistics-Theory and Methods 2000; 29:699-733. DOI: 10.1080/03610920008832511.
4. Gurka MJ, Edwards LJ, Muller KE, Kupper LL. Extending the Box-Cox transformation to the linear mixed model. Journal of the Royal Statistical Society, Series A 2006; 169:273-288. DOI: 10.1111/j.1467-985X.2005.00391.x.
5. Peltier MR, Wilcox CJ, Sharp DC. Technical note: application of the Box-Cox data transformation to animal science experiments. Journal of Animal Science 1998; 76:847-849.
6. Jacqmin-Gadda H, Thiébaut R, Chêne G, Commenges D. Analysis of left-censored longitudinal data with application to viral load in HIV infection. Biostatistics 2000; 1:355-368. DOI: 10.1093/biostatistics/1.4.355.
7. Beal SL. Ways to fit a PK model with some data below the quantification limit. Journal of Pharmacokinetics and Pharmacodynamics 2001; 28:481-504. DOI: 10.1023/A:1012299115260.
8. Han C, Kronmal R. Box-Cox transformation of left-censored data with application to the analysis of coronary artery calcification and pharmacokinetic data. Statistics in Medicine 2004; 23:3671-3679. DOI: 10.1002/sim.1925.
9. Hansen WB, Graham JW. Preventing alcohol, marijuana, and cigarette use among adolescents: peer pressure resistance training versus established conservative norms. Preventive Medicine 1991; 20:414-430. DOI: 10.1016/0091-7435(91)90039-7.
10. Davis CS. The analysis of longitudinal studies having non-normal response. In Statistical Analysis of Medical Data: New Developments, Dunn G (ed.). Arnold: London, 1998.
11. Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Annals of the Rheumatic Diseases 2005; 64:65-68. DOI: 10.1136/ard.2004.031237.
12. Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157:238-244. DOI: 10.1159/000250839.
13. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology 1959; 32:50-55.
14. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale for schizophrenia. Schizophrenia Bulletin 1987; 13:261-276. DOI: 10.1016/0165-1781(88)90038-8.
15. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis and Rheumatism 1980; 23:137-145. DOI: 10.1002/art.1780230202.
16. Tsonaka R, Rizopoulos D, Lesaffre E. Power and sample size calculations for discrete bounded outcome scores. Statistics in Medicine 2006; 25:4241-4252. DOI: 10.1002/sim.2679.
17. Sheiner LB, Beal SL. Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squares. Journal Pharmacokinetics and Biopharmaceutics 1985; 13:185-201. DOI: 10.1007/BF01059398.
18. Beal SL. Population pharmacokinetic data and parameter estimation based on their first two statistical moments. Drug Metabolism Reviews 1984; 15:173-193. DOI: 10.3109/03602538409015064.
19. Vonesh EF, Chinchilli VM. Linear and Nonlinear Models for the Analysis of Repeated Measurements. Marcel Dekker: New York, 1997; 445-459.
20. Lindstrom MJ, Bates DM. Nonlinear mixed effects models for repeated measures data. Biometrics 1990; 46:673-687.
21. Wolfinger R. Laplace's approximation for nonlinear mixed effects models. Biometrika 1993; 80:791-795.
22. Pinheiro JC, Bates DM. Approximations to the log-likelihood function in the nonlinear mixed effects model. Journal of Computational and Graphical Statistics 1995; 4:12-35.
23. Beal SL, Sheiner LB, Boeckmann AJ. NONMEM Users Guides. Icon Development Solutions: Ellicott City, Maryland, U.S.A., 1989-2006.
24. Lesaffre E, Rizopoulos D, Tsonaka R. The logistic transform for bounded outcome scores. Biostatistics 2007; 8:72-85. DOI: 10.1093/biostatistics/kxj034.
25. Heitjan D, Rubin D. Ignorability and coarse data. Annals of Statistics 1991; 19:2244-2253.
26. Heitjan D. Ignorability and coarse data: some biomedical examples. Biometrics 1993; 49:1099-1109.
27. Molas M, Lesaffre E. A comparison of three random effects approaches to analyze repeated bounded outcome scores with an application in a stroke revalidation study. Statistics in Medicine 2008; 27:6612-6633. DOI: 10.1002/sim.3432.
28. Lachenbruch PA. Analysis of data with excess zeros. Statistical Methods in Medical Research 2002; 11:297-302. DOI: 10.1191/0962280202sm289ra.
29. Berk KN, Lachenbruch PA. Repeated measures with zeros. Statistical Methods in Medical Research 2002; 11:303-316. DOI: 10.1191/0962280202sm293ra.
30. Aranda-Ordaz FJ. On two families of transformations to additivity for binary response data. Biometrika 1981; 68:357-363. DOI: 10.1093/biomet/68.2.357.
31. Mosteller F, Tukey JW. Data Analysis and Regression. Addison-Wesley: Reading, MA, 1977.
32. SAS Institute Inc. SAS/STAT 9.1 User's Guide. SAS Institute Inc: Cary, NC, 2004.
33. Molas M, Lesaffre E. A comparison of three random effects approaches to analyze repeated bounded outcome scores with an application in a stroke revalidation study. Statistics in Medicine 2008; 27:6612-6633. DOI: 10.1002/sim.3432.
34. Olsen MK, Schafer JL. A two-part random-effects model for semicontinuous longitudinal data. Journal of the American Statistical Association 2001; 96:730-745.
35. Johnston JA, Bacon CM, Riedy MC, O'Shea JJ. Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency. Journal of Leukocyte Biololgy 1996; 60:441-452.
36. Su L, Tom BD, Farewell VT. Bias in 2-part mixed models for longitudinal semicontinuous data. Biostatistics 2009; 10:374-8910. DOI: 10.1093/biostatistics/kxn044.
37. Sheiner LB, Beal SL, Dunne A. Analysis of nonrandomly censored ordered categorical longitudinal data from analgesic trials. Journal of the American Statistical Association 1997; 92:1235-1244.
38. Holford NHG, Chan PLS, Nutt JG, Kieburtz K. Disease progression and pharmacodynamics in Parkinson disease-evidence for functional protection with levodopa and other treatments. Journal of Pharmacokinetics and Pharmacodynamics 2006; 33:281-311. DOI: 10.1007/s10928-006-9012-6.
39. Dayneka NL, Garg V, Jusko WJ. Comparison of four basic models of indirect pharmacodynamic responses. Journal Pharmacokinetics and Biopharmaceutics 1993; 21:457-478. DOI: 10.1007/BF01061691.
40. Hutmacher MM, Krishnaswami S, Kowalski KG. Exposure-response modeling using latent variables for the efficacy of a JAK3 inhibitor administered to rheumatoid arthritis patients. Journal of Pharmacokinetics and Pharmacodynamics 2008; 35:139-157. DOI: 10.1007/s10928-007-9080-2.
41. Yano Y, Beal SL, Sheiner LB. Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check. Journal of Pharmacokinetics and Pharmacodynamics 2001; 28:171-192. DOI: 10.1023/A:1011555016423.
42. Moulton LH, Halsey NA. A mixture model with detection limits for regression analysis of antibody response to vaccine. Biometrics 1995; 51:1570-1578.
43. Oberg A, Davidian M. Estimating data transformations in nonlinear mixed effect models. Biometrics 2000; 56:65-72. DOI: 10.1111/j.0006-341X.2000.00065.x.